Kwanan nan, ni da abokin aikina mun kammala nazari akai-akai game da munanan illolin da ke tattare da allurar rigakafin covid-19.
Marubuci na Peter Gøtzsche, likita ne na Danish tare da shekaru arba'in na kwarewar bincike, yana buga takardun 97 a cikin "manyan biyar" (BMJ, Lancet, Jama,Annals of Internal Medicine, da kuma New England Journal of Medicine) da kuma 19 Cochrane reviews.
Na baya Rahoton kan yadda aka yi watsi da mummunan cutarwa ko kuma aka cire su daga gwaji na covid-19, ya zama yunƙurin wannan bita.
Hakanan, an tayar da damuwa game da amincin bayanan gwaji na asibiti saboda masana'antar harhada magunguna dogon tarihi na gurbata bayanai da kuma boye illolin da gangan.
A game da alluran rigakafin covid-19, masana'antun rigakafin, ko masu kula da magunguna ba su yarda masu bincike masu zaman kansu su yi ba. bincika da raw gwaji data, tilasta nuna gaskiya masu ba da shawara ga tuhumar FDA don samun dama ga takardun.
A cikin sharhinmu, mun mayar da hankali kan Mummunan abubuwan da suka faru (SAEs) hade da alluran rigakafin covid-19, da aka rubuta a cikin wallafe-wallafen da aka buga (ranar da aka yanke bincike shine 4 ga Afrilu 2022).
Mun ayyana SAEs bisa ga Hukumar Kula da Magunguna ta Turai definition:
Mummunan halayen da ke haifar da mutuwa, yana da barazanar rai, yana buƙatar asibiti ko tsawaita jinyar da ake ciki, yana haifar da naƙasa ko babba ko rashin ƙarfi, ko lahani na haihuwa.
Ga mahimman abubuwan:
- Yawancin binciken da muka sake dubawa ba su da inganci sosai kuma an buga su a cikin mujallu waɗanda suka kasa gano ainihin kurakurai.
- Har zuwa yau, mafi tsananin tsayayyen tsarin bita na SAEs ya gudanar da shi Fraiman et al, wanda ya sake nazarin bayanan gwaji daga gwaje-gwaje masu mahimmanci guda biyu na rigakafin mRNA (Pfizer & Moderna), ciki har da SAEs daga shafukan yanar gizon FDA da Health Canada. Hadarin SAE bayan allurar rigakafin ya wuce haɗarin asibiti daga covid-19.
- Magungunan maganin rigakafi na adenovirus sun ƙara haɗarin thrombosis venous da thrombocytopenia. (Hukumomi sun mayar da martani dakatarwa Amfani da maganin AstraZeneca a duk ƙasashen Turai, kuma a cikin Amurka, masu gudanarwa sun ba da shawarar ƙuntataccen amfani na rigakafin Janssen).
- Magungunan da ke tushen mRNA sun ƙara haɗarin myocarditis, tare da mace-mace kusan 1-2 a cikin 200 lokuta. Ya fi kowa a cikin samari maza.
- Mun sami shaidar munanan illolin jijiya, da suka haɗa da palsy Bell, Guillain-Barré syndrome, myasthenic cuta, da bugun jini, waɗanda mai yiwuwa ne saboda amsawar autoimmune daga mRNA da allurar rigakafi na adenoviral vector.
- Mummunan lahani, watau waɗanda ke hana ayyukan yau da kullun, ba a ba da rahotonsu ba a cikin gwaje-gwajen da aka yi bazuwar.
- Cutarwa mai tsanani sun kasance ruwan dare a cikin binciken mutanen da ke da cikakken alurar riga kafi suna samun abubuwan ƙarfafawa (kashi na 3), da kuma a cikin binciken allurar rigakafin mutanen da suka kamu da cutar a baya (watau waɗanda ke da rigakafi ta zahiri).
- Masu kula da sha da fataucin miyagun kwayoyi da sauran hukumomi sun yi tafiyar hawainiya wajen bibiyar alamun munanan illoli.
- Dangane da matsalolin samun bayanan ka'idoji, rufa-rufa, da kuma rubutattun rahoto, mun ga akwai yuwuwar akwai wasu munanan illolin allurar rigakafin cutar ta covid-19, fiye da wadanda aka gano kawo yanzu.
- Shawarwari na yawan jama'a don rigakafin cutar ta covid da masu haɓakawa sun yi watsi da mummunan fa'ida don cutar da daidaituwa a cikin ƙananan ƙungiyoyin haɗari kamar yara da mutanen da suka riga sun murmure daga covid-19 (kariyar rigakafi).
An loda cikakken rubutun a matsayin a Pre-PRINT.
Sake bugawa daga marubucin Mayarwa
-
Maryanne Demasi, 2023 Brownstone Fellow, ɗan rahoto ne na likita mai bincike tare da PhD a cikin ilimin rheumatology, wanda ya rubuta don kafofin watsa labarai na kan layi da manyan mujallu na likita. Sama da shekaru goma, ta samar da shirye-shiryen talabijin na Kamfanin Watsa Labarai na Australiya (ABC) kuma ta yi aiki a matsayin mai rubuta magana da mai ba da shawara kan harkokin siyasa na Ministan Kimiyya na Kudancin Australiya.
Duba dukkan posts
